Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Provectus Biopharmaceuticals, Inc. (PVCT)
USD0.06
0.00 (-2.00%)
US OTC Healthcare Biotechnology
Address
10025 Investment Drive 37932
Knoxville, TN, US
Knoxville, TN, US
CEO
Edward V. Pershing
Website
provectusbio.com
IPO
1997-01-15
CIK 315545 ISIN US74373P1084
Description
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology firm dedicated to pioneering immunotherapy treatments. These therapies are grounded in its proprietary halogenated xanthene platform. Among its key developments is PV-10, an experimental autolytic cancer immunotherapy. This treatment is being explored for a range of adult solid tumor malignancies, encompassing melanoma and various gastrointestinal cancers (such as hepatocellular carcinoma, metastatic colorectal cancer to the liver, metastatic neuroendocrine tumors to the liver, and metastatic uveal melanoma to the liver). It also targets pediatric solid tumors, including neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and osteosarcoma. Additionally, Provectus is advancing oral formulations of pharmaceutical-grade rose bengal sodium (cGMP RBS) to combat a broad spectrum of conditions. These include adult solid tumors (such as head and neck, breast, testicular, and colorectal cancers), pediatric blood cancers like leukemia, acute respiratory syndromes such as coronavirus, infections caused by multi-drug resistant bacteria (specifically Gram-negative bacteria), and certain ocular conditions, notably infectious keratitis. Furthermore, the company is progressing PH-10, an investigational immuno-dermatology agent designed to address inflammatory skin conditions like psoriasis and atopic dermatitis. Originally established in 2002, the company was initially named Provectus Pharmaceuticals, Inc., before rebranding as Provectus Biopharmaceuticals, Inc. in December 2013. Its operations are headquartered in Knoxville, Tennessee.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.06
0.00 (-2.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
157.9K
Beta
0.83
Float Shares
386.66M
Free Float %
92.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.30% | +8.36% | +27.50% | +47.68% | +7.86% | +25.22% | -16.17% | -49.96% | +2.94% | -82.50% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.06
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-674.69
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-45.5% Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-14.2% Q1'26: -14.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-1,238.1%
-
EBIT margin Biotechnology: +0.0%-1,441.3%
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+0.1% ★ Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.62×
Valuation Multiples
From
To
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.80M
OE per share TTM
-0.01
Owner's Yield
-9.51%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
34.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
1
Total invested
5.1K
Insider transactions (90d)
2
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Jeffrey Allen Morris | 61.10M | 11.30% | 61.10M | — | 61.10M | — | IN | United States of America | 2024-08-14 | ↗ |
| 2 | Allen Morris | 56.57M | 13.50% | 56.57M | — | 56.57M | — | IN | United States of America | 2023-03-28 | ↗ |
| 3 | Edward Pershing, CPA | 22.64M | 5.17% | 22.47M | 162.4K | 22.47M | 10.00 | IN | OR PLACE OF ORGANIZATION | 2024-07-03 | ↗ |
| 4 | Eric Wachter | 21.03M | 5.00% | 21.03M | — | 21.03M | 10.00 | IN | OR PLACE OF ORGANIZATION | 2021-06-30 | ↗ |
| 5 | Donald Adams | 6.62M | 18.65% | 6.62M | — | 6.62M | — | IN | US | 2006-03-28 | ↗ |
| 6 | Page | 5.26M | 12.00% | — | 5.26M | — | 5.26M | IN | of 8 Pages | 2010-06-01 | ↗ |
| 7 | Ltd | 5.26M | 6.30% | — | 5.26M | — | — | IA | Bermuda | 2010-06-01 | ↗ |
| 8 | Chris Kuchanny | 4.05M | 5.21% | — | 4.05M | — | — | IN | United Kingdom | 2012-02-14 | ↗ |
| 9 | Revelation Capital Management Ltd | 4.05M | 5.21% | — | 4.05M | — | — | IA | Bermuda | 2012-02-14 | ↗ |
| 10 | Revelation Special Situations Fund Ltd | 4.05M | 5.21% | — | 4.05M | — | — | IV | Bermuda | 2012-02-14 | ↗ |
| 11 | Centrecourt Asset Management LLC** | 3.66M | 9.99% | 3.66M | — | 3.66M | — | OO | United States | 2006-02-07 | ↗ |
| 12 | DC Opportunity Advisors LLC | 3.60M | 9.99% | — | 3.60M | — | 3.60M | OO | United States | 2005-04-14 | ↗ |
| 13 | DCOFI Master LDC | 3.60M | 9.99% | — | 3.60M | — | 3.60M | OO | Cayman Islands | 2005-04-14 | ↗ |
| 14 | Richard Smithline | 2.35M | 6.00% | 2.35M | — | 2.35M | — | IN | United States | 2006-08-21 | ↗ |
| 15 | CAMOFI Master LDC | 2.24M | 5.80% | 2.24M | — | 2.24M | — | OO | Cayman Islands | 2006-08-21 | ↗ |
| 16 | Centrecourt Asset Management LLC | 2.24M | 5.80% | 2.24M | — | 2.24M | — | OO | United States | 2006-08-21 | ↗ |
| 17 | Alpha Capital Aktiengesellschaft | 1.17M | 5.80% | 1.17M | — | 1.17M | — | CO | Liechtenstein | 2006-02-08 | ↗ |
| 18 | Castlerigg International Holdings Limited | 963.0K | 2.40% | — | 963.0K | — | 963.0K | CO | British Virgin Islands | 2007-02-14 | ↗ |
| 19 | Castlerigg International Limited | 963.0K | 2.40% | — | 963.0K | — | 963.0K | CO | British Virgin Islands | 2007-02-14 | ↗ |
| 20 | Castlerigg Master Investments Ltd. | 963.0K | 2.40% | — | 963.0K | — | 963.0K | CO | British Virgin Islands | 2007-02-14 | ↗ |
| 21 | Sandell Asset Management Corp. | 963.0K | 2.40% | — | 963.0K | — | 963.0K | CO | British Virgin Islands | 2007-02-14 | ↗ |
| 22 | Thomas E. Sandell | 963.0K | 2.40% | — | 963.0K | — | 963.0K | IN | Sweden | 2007-02-14 | ↗ |
| 23 | DC Asset Management LLC | 566.7K | 3.33% | — | 566.7K | — | 566.7K | OO | United States | 2005-04-14 | ↗ |
| 24 | CAM Opportunity Advisors LLC** | — | 0.00% | — | — | — | — | OO | United States | 2006-02-07 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
1
-3 vs prev Q
New positions
0
Closed positions
3
Increased
0
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | HOME FEDERAL BANK OF TENNESSEE | 100.0K +— (+0.0%) | 5.1K -500.0 (-8.9%) | 0.02% +0.000 pp | 0.00% 0.000 pp | USD0.39 -87.2% | 42 qtrs — |
| 2 | ACADEMY CAPITAL MANAGEMENT INC/TX | 20.0K +— (+0.0%) | 1.0K -100.0 (-8.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.09 -44.4% | 34 qtrs — |
| 3 | ATLAS WEALTH LLC | 19.6K +19.6K (+100.0%) | 999.00 +999.0 (+100.0%) | 0.00% +0.005 pp | 0.00% +0.000 pp | USD0.05 +0.0% | 14 qtrs — |
| 4 | FINANCIAL SYMMETRY INC | 10.2K +— (+0.0%) | 581.00 +11.0 (+1.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.10 -50.0% | 10 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Buys
3
Sells
3
Shares acquired
83.1K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+83,055
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 18,876 | 0.00 | — | 2,793,109 | D | ↗ |
| 2026-04-29 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 30,202 | 0.00 | — | 2,774,233 | D | ↗ |
| 2026-04-04 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 33,977 | 0.00 | — | 2,744,031 | D | ↗ |
| 2026-03-25 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-03-20 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 49,067 | 0.00 | — | 2,710,054 | D | ↗ |
| 2026-03-12 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-03-05 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-02-26 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-02-20 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 47,180 | 0.00 | — | 2,660,987 | D | ↗ |
| 2026-02-19 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-02-12 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-02-09 | Pershing Edward | Director / Officer | P-Purchase | A | Series D-1 Convertible Preferred Stock | 34,940 | 0.00 | — | 2,613,807 | D | ↗ |
| 2026-02-05 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-01-30 | Pershing Edward | Director / Officer | M-Exempt | D | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-01-28 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2026-01-16 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 37,744 | 0.00 | — | 2,541,123 | D | ↗ |
| 2025-12-11 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-12-05 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-11-26 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-11-20 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-11-13 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-11-06 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-10-30 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-10-23 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-10-16 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 18,880 | 0.00 | — | 2,503,379 | D | ↗ |
| 2025-10-10 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-10-03 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-09-30 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 66,052 | 0.00 | — | 2,484,499 | D | ↗ |
| 2025-09-19 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 37,760 | 0.00 | — | 2,418,447 | D | ↗ |
| 2025-09-18 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-09-11 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-09-04 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-08-29 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 28,320 | 0.00 | — | 2,380,687 | D | ↗ |
| 2025-08-26 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-08-22 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 37,760 | 0.00 | — | 2,352,367 | D | ↗ |
| 2025-08-08 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 18,880 | 0.00 | — | 2,314,607 | D | ↗ |
| 2025-07-18 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 62,303 | 0.00 | — | 2,295,727 | D | ↗ |
| 2025-06-26 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 122,692 | 0.00 | — | 2,233,424 | D | ↗ |
| 2025-06-20 | Pershing Edward | Director / Officer | M-Exempt | D | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-06-05 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-05-23 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-05-15 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-05-07 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-04-29 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 18,876 | 0.00 | — | 2,091,852 | D | ↗ |
| 2025-04-19 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 9,438 | 0.00 | — | 2,072,976 | D | ↗ |
| 2025-04-11 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 7,551 | 0.00 | — | 2,063,538 | D | ↗ |
| 2025-04-04 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-03-26 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 150,975 | 0.00 | — | 2,055,987 | D | ↗ |
| 2025-03-21 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 9,436 | 0.00 | — | 1,905,012 | D | ↗ |
| 2025-03-20 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-02-27 | Pershing Edward | Director / Officer | M-Exempt | D | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-02-20 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-02-15 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 27,989 | 0.00 | — | 1,827,623 | D | ↗ |
| 2025-01-30 | Pershing Edward | Director / Officer | M-Exempt | D | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2025-01-16 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2024-12-28 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 37,760 | 0.00 | — | 1,748,344 | D | ↗ |
| 2024-12-02 | WACHTER ERIC PHD | Officer | A-Award | A | Stock Options (Right to Buy) | 2,138,548 | 0.29 | 612.1K | 2,138,548 | D | ↗ |
| 2024-12-02 | Rodrigues Dominic | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 16,146,600 | 0.29 | 4.62M | 16,146,600 | D | ↗ |
| 2024-12-02 | Raines Heather | Officer | A-Award | A | Stock Options (Right to Buy) | 4,197,890 | 0.29 | 1.20M | 4,197,890 | D | ↗ |
| 2024-12-02 | Pershing Edward | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 25,470,215 | 0.29 | 7.29M | 25,470,215 | D | ↗ |
| 2024-12-02 | Lacey John III | Director | A-Award | A | Stock Options (Right to Buy) | 775,082 | 0.29 | 221.8K | 775,082 | D | ↗ |
| 2024-12-02 | Bailey Webster | Director | A-Award | A | Stock Options (Right to Buy) | 775,082 | 0.29 | 221.8K | 775,082 | D | ↗ |
| 2024-11-29 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 18,880 | 0.00 | — | 1,710,584 | D | ↗ |
| 2024-11-22 | Pershing Edward | Director / Officer | P-Purchase | A | Series D-1 Convertible Preferred Stock | 80,365 | 0.00 | — | 1,691,704 | D | ↗ |
| 2024-10-16 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2024-09-30 | Rodrigues Dominic | Director / Officer | A-Award | A | Series D-1 Convertible Preferred Stock | 196,250 | 0.00 | — | 1,337,876 | D | ↗ |
| 2024-09-30 | Pershing Edward | Director / Officer | A-Award | A | Series D-1 Convertible Preferred Stock | 168,367 | 0.00 | — | 1,611,339 | D | ↗ |
| 2024-09-30 | Lacey John III | Director | A-Award | A | Series D-1 Convertible Preferred Stock | 179,592 | 0.00 | — | 179,592 | D | ↗ |
| 2024-09-30 | Bailey Webster | Director | A-Award | A | Series D-1 Convertible Preferred Stock | 117,295 | 0.00 | — | 158,618 | D | ↗ |
| 2024-09-19 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | D | ↗ |
| 2024-08-29 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-08-22 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-08-12 | Morris Jeffrey Allen | 10% Owner | C-Conversion | A | Series D-1 Convertible Preferred Stock | 264,314 | 2.86 | 756.5K | 4,260,061 | — | ↗ |
| 2024-08-08 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-08-03 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 28,320 | 0.00 | — | 1,442,972 | — | ↗ |
| 2024-07-20 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 47,199 | 0.00 | — | 1,414,652 | — | ↗ |
| 2024-07-18 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-06-30 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 47,180 | 0.00 | — | 1,367,453 | — | ↗ |
| 2024-06-26 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-06-25 | Rodrigues Dominic | Director / Officer | A-Award | A | Series D-1 Convertible Preferred Stock | 1,141,626 | 0.00 | — | 1,141,626 | — | ↗ |
| 2024-06-20 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-06-15 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 47,190 | 0.00 | — | 1,320,273 | — | ↗ |
| 2024-05-26 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 18,876 | 0.00 | — | 1,273,083 | — | ↗ |
| 2024-05-12 | Pershing Edward | Director / Officer | M-Exempt | D | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-04-29 | Pershing Edward | Director / Officer | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-04-25 | Pershing Edward | Director / Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 37,752 | 0.00 | — | 1,178,704 | — | ↗ |
| 2024-04-19 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-04-11 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-04-06 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 47,190 | 0.00 | — | 1,140,952 | — | ↗ |
| 2024-03-26 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-03-21 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-03-17 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 47,190 | 0.00 | — | 1,093,762 | — | ↗ |
| 2024-02-28 | Raines Heather | Officer | D-Return | D | 8% Unsecured Convertible Promissory Note due 2022 | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-02-27 | Pershing Edward | Director | M-Exempt | D | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-02-17 | Pershing Edward | Director | M-Exempt | D | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-02-15 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-02-02 | Raines Heather | Officer | D-Return | D | 8% Unsecured Convertible Promissory Note due 2022 | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-01-30 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2024-01-26 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 47,180 | 0.00 | — | 961,648 | — | ↗ |
| 2024-01-12 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 47,180 | 0.00 | — | 914,468 | — | ↗ |
| 2023-12-28 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-12-22 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 9,440 | 0.00 | — | 876,728 | — | ↗ |
| 2023-12-19 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 37,760 | 0.00 | — | 867,288 | — | ↗ |
| 2023-12-02 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 56,628 | 0.00 | — | 829,528 | — | ↗ |
| 2023-11-29 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-11-15 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 9,440 | 0.00 | — | 772,920 | — | ↗ |
| 2023-11-08 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 37,744 | 0.00 | — | 763,480 | — | ↗ |
| 2023-11-01 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 13,216 | 0.00 | — | 725,736 | — | ↗ |
| 2023-10-27 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 2,832 | 0.00 | — | 712,520 | — | ↗ |
| 2023-10-14 | Pershing Edward | Director | M-Exempt | D | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-10-03 | Pershing Edward | Director | P-Purchase | A | Series D-1 Convertible Preferred Stock | 19,311 | 0.00 | — | 690,800 | — | ↗ |
| 2023-09-30 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 41,518 | 0.00 | — | 671,489 | — | ↗ |
| 2023-09-23 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 28,320 | 0.00 | — | 629,971 | — | ↗ |
| 2023-09-01 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 37,760 | 0.00 | — | 601,651 | — | ↗ |
| 2023-08-11 | Morris Jeffrey Allen | 10% Owner | A-Award | A | 8% Secured Convertible Promissory Note | 0 | 2.86 | — | 244,584 | — | ↗ |
| 2023-08-03 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-07-28 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 28,326 | 0.00 | — | 563,891 | — | ↗ |
| 2023-07-24 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 56,639 | 0.00 | — | 535,565 | — | ↗ |
| 2023-07-20 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-06-30 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-06-15 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-05-26 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-05-12 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-05-08 | Morris Jeffrey Allen | 10% Owner | C-Conversion | A | Series D-1 Convertible Preferred Stock | 188,757 | 2.86 | 540.2K | 3,995,747 | — | ↗ |
| 2023-05-05 | Morris Jeffrey Allen | 10% Owner | — | D | 8% Secured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-04-25 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-04-06 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-03-27 | Morris Jeffrey Allen | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 18,500,000 | — | ↗ |
| 2023-03-17 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-02-17 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2023-01-26 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 125,000.00 | — | 0 | — | ↗ |
| 2023-01-12 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 125,000.00 | — | 0 | — | ↗ |
| 2022-12-02 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note due 2023 | 0 | 150,000.00 | — | 0 | — | ↗ |
| 2022-11-15 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note due 2023 | 0 | 25,000.00 | — | 0 | — | ↗ |
| 2022-11-08 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note due 2023 | 0 | 100,000.00 | — | 0 | — | ↗ |
| 2022-11-01 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note due 2023 | 0 | 35,000.00 | — | 0 | — | ↗ |
| 2022-10-27 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note due 2023 | 0 | 7,500.00 | — | 0 | — | ↗ |
| 2022-09-16 | Rodrigues Dominic | Director | P-Purchase | A | Series D Convertible Preferred Stock | 11,416,262 | 0.00 | — | 11,416,262 | — | ↗ |
| 2022-09-01 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note | 0 | 2.86 | — | 0 | — | ↗ |
| 2022-07-15 | Pershing Edward | Director | A-Award | A | 8% Unsecured Convertible Promissory Note due 2023 | 0 | 75,000.00 | — | 0 | — | ↗ |
| 2021-08-16 | Raines Heather | Officer | A-Award | A | 8% Unsecured Convertible Promissory Note due 2022 | 0 | 2.86 | — | 0 | — | ↗ |
| 2021-06-20 | WACHTER ERIC PHD | Officer | M-Exempt | D | 8% Secured Convertible Promissory Notes due 2021 | 0 | 2.86 | — | 0 | — | ↗ |
| 2021-06-20 | Raines Heather | Officer | M-Exempt | A | Series D-1 Convertible Preferred Stock | 20,289 | 0.00 | — | 20,289 | — | ↗ |
| 2021-06-20 | Pershing Edward | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 478,926 | 0.00 | — | 478,926 | — | ↗ |
| 2021-06-20 | Horowitz Bruce | Director / Officer | M-Exempt | D | 8% Secured Convertible Promissory Notes due 2021 | 0 | 2.86 | — | 0 | — | ↗ |
| 2021-06-20 | Bailey Webster | Director | M-Exempt | A | Series D-1 Convertible Preferred Stock | 41,323 | 0.00 | — | 41,323 | — | ↗ |
| 2021-06-17 | WACHTER ERIC PHD | Officer | A-Award | A | 8% Secured Convertible Promissory Notes due 2021 | 0 | 2.86 | — | 0 | — | ↗ |
| 2021-06-17 | Raines Heather | Officer | A-Award | A | 8% Secured Convertible Promissory Notes due 2021 | 0 | 2.86 | — | 0 | — | ↗ |
| 2021-06-17 | Pershing Edward | Director | A-Award | A | 8% Secured Convertible Promissory Notes due 2021 | 0 | 2.86 | — | 0 | — | ↗ |
| 2021-06-17 | Horowitz Bruce | Director / Officer | A-Award | A | 8% Secured Convertible Promissory Notes due 2021 | 0 | 2.86 | — | 0 | — | ↗ |
| 2021-06-17 | Bailey Webster | Director | A-Award | A | 8% Secured Convertible Promissory Notes due 2021 | 0 | 2.86 | — | 0 | — | ↗ |
| 2020-11-10 | Raines Heather | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 1,213,153 | — | ↗ |
| 2020-11-10 | Lacy John III | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 200,000 | — | ↗ |
| 2020-11-10 | Horowitz Bruce | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 2,425,000 | 0.12 | 291.0K | 2,425,000 | — | ↗ |
| 2020-07-13 | Bailey Webster | Director | — | I | Common Stock | 0 | 0.00 | — | 25,528 | — | ↗ |
| 2019-03-25 | Raines Heather | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,113,153 | — | ↗ |
| 2018-04-27 | Pershing Edward | Director | — | D | Common Stock | 0 | 0.00 | — | 2,820,630 | — | ↗ |
| 2018-04-27 | Lacy John III | Director | — | D | Common Stock | 0 | 0.00 | — | 100,000 | — | ↗ |
| 2017-12-14 | Glass John R | Officer | P-Purchase | A | Common Stock | 115,900 | 0.05 | 6.3K | 200,000 | — | ↗ |
| 2017-04-03 | Rodrigues Dominic | Director | — | I | Common Stock | 0 | 0.00 | — | 3,775 | — | ↗ |
| 2017-04-03 | Horowitz Bruce | Director | — | D | Common Stock Warrants (right to buy) | 400,000 | 0.85 | 340.0K | 0 | — | ↗ |
| 2016-12-28 | CULPEPPER PETER R | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-04-19 | Glass John R | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-03-29 | WACHTER ERIC PHD | Director / Officer | O-OutOfTheMoney | A | Common Stock | 106,000 | 1.00 | 106.0K | 930,248 | — | ↗ |
| 2016-03-29 | Koe Jan | Director | O-OutOfTheMoney | A | Common Stock | 100,000 | 1.25 | 125.0K | 786,300 | — | ↗ |
| 2016-03-29 | CULPEPPER PETER R | Officer | O-OutOfTheMoney | A | Common Stock Warrants (right to buy) | 133,333 | 0.85 | 113.3K | 133,333 | — | ↗ |
| 2015-12-21 | WACHTER ERIC PHD | Officer | M-Exempt | A | Common Stock | 120,000 | 1.02 | 122.4K | 5,513,236 | — | ↗ |
| 2015-12-09 | WACHTER ERIC PHD | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 0.75 | 300.0K | 400,000 | — | ↗ |
| 2015-12-09 | Smith Alfred E. IV | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.75 | 37.5K | 50,000 | — | ↗ |
| 2015-12-09 | SCOTT TIMOTHY PHD | Director / Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 0.75 | 300.0K | 400,000 | — | ↗ |
| 2015-12-09 | McMasters Kelly M | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.75 | 37.5K | 50,000 | — | ↗ |
| 2015-12-09 | Koe Jan | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.75 | 37.5K | 50,000 | — | ↗ |
| 2015-12-09 | DEES H CRAIG | Director / Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 0.75 | 300.0K | 400,000 | — | ↗ |
| 2015-12-09 | CULPEPPER PETER R | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 0.75 | 300.0K | 400,000 | — | ↗ |
| 2015-01-24 | WACHTER ERIC PHD | Officer | M-Exempt | A | Common Stock | 185,000 | 1.02 | 188.7K | 824,248 | — | ↗ |
| 2015-01-07 | SCOTT TIMOTHY PHD | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 76,764 | 0.64 | 49.1K | 0 | — | ↗ |
| 2015-01-07 | CULPEPPER PETER R | Officer | M-Exempt | D | Stock Option (right to buy) | 33,334 | 0.75 | 25.0K | 0 | — | ↗ |
| 2014-12-30 | SCOTT TIMOTHY PHD | Director / Officer | M-Exempt | A | Common Stock | 126,361 | 0.64 | 80.9K | 426,361 | — | ↗ |
| 2014-10-29 | SCOTT TIMOTHY PHD | Director / Officer | M-Exempt | A | Common Stock | 96,875 | 0.64 | 62.0K | 1,521,845 | — | ↗ |
| 2014-10-03 | SCOTT TIMOTHY PHD | Officer | J-Other | D | Stock Option (right to buy) | 475,000 | 0.93 | 441.8K | 475,000 | — | ↗ |
| 2014-10-03 | DEES H CRAIG | Director / Officer | J-Other | D | Stock Option (right to buy) | 475,000 | 1.00 | 475.0K | 475,000 | — | ↗ |
| 2014-10-03 | CULPEPPER PETER R | Officer | J-Other | D | Stock Option (right to buy) | 450,000 | 0.93 | 418.5K | 450,000 | — | ↗ |
| 2014-07-29 | Smith Alfred E. IV | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.88 | 44.0K | 50,000 | — | ↗ |
| 2014-07-29 | McMasters Kelly M | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.88 | 44.0K | 50,000 | — | ↗ |
| 2014-07-29 | Koe Jan | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.88 | 44.0K | 50,000 | — | ↗ |
| 2014-06-28 | CULPEPPER PETER R | Officer | M-Exempt | A | Common Stock | 100,000 | 1.25 | 125.0K | 1,112,332 | — | ↗ |
| 2014-05-19 | SCOTT TIMOTHY PHD | Officer | M-Exempt | D | Common Stock | 25,000 | 0.95 | 23.8K | 1,424,970 | — | ↗ |
| 2014-03-20 | WACHTER ERIC PHD | Officer | M-Exempt | A | Common Stock | 600,000 | 0.93 | 558.0K | 6,032,484 | — | ↗ |
| 2014-02-26 | SCOTT TIMOTHY PHD | Officer | M-Exempt | A | Common Stock | 300,000 | 1.10 | 330.0K | 300,000 | — | ↗ |
| 2014-02-26 | CULPEPPER PETER R | Officer | M-Exempt | A | Common Stock | 68,624 | 1.10 | 75.5K | 1,012,332 | — | ↗ |
| 2013-09-20 | Koe Jan | Director | P-Purchase | A | Common Stock | 100,000 | 0.75 | 75.0K | 586,300 | — | ↗ |
| 2013-08-19 | Smith Alfred E. IV | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.67 | 33.5K | 50,000 | — | ↗ |
| 2013-08-19 | SCOTT TIMOTHY PHD | Director / Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 0.67 | 33.5K | 50,000 | — | ↗ |
| 2013-08-19 | McMasters Kelly M | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.67 | 33.5K | 50,000 | — | ↗ |
| 2013-08-19 | Koe Jan | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 0.67 | 33.5K | 50,000 | — | ↗ |
| 2013-08-19 | DEES H CRAIG | Director / Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 0.67 | 33.5K | 50,000 | — | ↗ |
| 2013-05-29 | DEES H CRAIG | Director / Officer | M-Exempt | A | Common Stock | 25,000 | 0.60 | 15.0K | 1,497,859 | — | ↗ |
| 2012-12-03 | CULPEPPER PETER R | Officer | P-Purchase | A | Common Stock | 133,333 | 0.75 | 100.0K | 943,708 | — | ↗ |
| 2012-11-16 | WACHTER ERIC PHD | Officer | P-Purchase | A | Common Stock | 666,666 | 0.75 | 500.0K | 5,393,236 | — | ↗ |
| 2012-11-16 | CULPEPPER PETER R | Officer | P-Purchase | A | Common Stock | 133,333 | 0.75 | 100.0K | 810,375 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-8.1K
Shares Outstanding
420.28M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Dominic Rodrigues, President | 240.0K | — | — | — | — | 75.0K | 315.0K | 0.00% | ↗ |
| 2 | 2025 | Edward Pershing, CPA, Chief Executive Officer | 240.0K | — | — | — | — | 75.0K | 315.0K | 0.00% | ↗ |
| 3 | 2025 | Eric Wachter, Ph.D., Chief Technology Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 4 | 2025 | Heather Raines, CPA, Chief Financial Officer | 200.0K | — | — | — | — | — | 200.0K | 0.00% | ↗ |
| 5 | 2024 | Edward Pershing, CPA, Chief Executive Officer | 170.0K | — | — | 1.90M | — | 75.0K | 2.15M | 88.59% | ↗ |
| 6 | 2024 | Dominic Rodrigues, President and Principal Executive Officer | 170.0K | — | — | 1.21M | — | 88.8K | 1.46M | 82.33% | ↗ |
| 7 | 2024 | Dominic Rodrigues, President | 170.0K | — | — | 1.21M | — | 88.8K | 1.46M | 82.33% | ↗ |
| 8 | 2024 | Heather Raines, CPA, Chief Financial Officer | 131.3K | — | — | 313.6K | — | — | 444.8K | 70.49% | ↗ |
| 9 | 2024 | Eric Wachter, Ph.D., Chief Technology Officer | 240.0K | — | — | 159.8K | — | — | 399.8K | 39.96% | ↗ |
| 10 | 2024 | Bruce Horowitz, Former Chief Operating Officer and Former Principal Executive Officer | 63.6K | — | — | — | — | — | 63.6K | 0.00% | ↗ |
| 11 | 2023 | Bruce Horowitz, Former Chief Operating Officer | 254.4K | — | — | — | — | 75.0K | 329.4K | 0.00% | ↗ |
| 12 | 2023 | Bruce Horowitz, Former Chief Operating Officer and Former Principal Executive Officer | 254.4K | — | — | — | — | — | 254.4K | 0.00% | ↗ |
| 13 | 2023 | Eric Wachter, Ph.D., Chief Technology Officer | 240.0K | — | — | — | — | — | 240.0K | 0.00% | ↗ |
| 14 | 2023 | Heather Raines, CPA, Chief Financial Officer | 125.0K | — | — | — | — | — | 125.0K | 0.00% | ↗ |
| 15 | 2022 | Bruce Horowitz, Former Chief Operating Officer | 254.4K | — | — | — | — | 75.0K | 329.4K | 0.00% | ↗ |
| 16 | 2022 | Eric Wachter, Ph.D., Chief Technology Officer | 240.0K | — | — | — | — | 14.2K | 254.2K | 0.00% | ↗ |
| 17 | 2022 | Bruce Horowitz, Chief Operating Officer | 169.6K | — | — | — | — | 75.0K | 244.6K | 0.00% | ↗ |
| 18 | 2022 | Heather Raines, CPA, Chief Financial Officer | 125.0K | — | — | — | — | — | 125.0K | 0.00% | ↗ |
| 19 | 2021 | Bruce Horowitz, Chief Operating Officer | 169.6K | — | — | — | — | 75.0K | 244.6K | 0.00% | ↗ |
| 20 | 2021 | Eric Wachter, Ph.D., Chief Technology Officer | 160.0K | — | — | — | — | 10.8K | 170.8K | 0.00% | ↗ |
| 21 | 2021 | Heather Raines, CPA, Chief Financial Officer | 83.3K | — | — | — | — | — | 83.3K | 0.00% | ↗ |
| 22 | 2020 | Bruce Horowitz, Chief Operating Officer | 254.4K | — | 52.0K | 62.8K | — | 75.0K | 444.2K | 25.84% | ↗ |
| 23 | 2020 | Eric Wachter, Ph.D., Chief Technology Officer | 220.0K | — | — | — | — | 10.9K | 230.9K | 0.00% | ↗ |
| 24 | 2020 | Heather Raines, CPA, Chief Financial Officer | 115.5K | — | 3.3K | — | — | — | 118.7K | 2.74% | ↗ |
| 25 | 2019 | Eric Wachter, Ph.D., Chief Technology Officer | 466.7K | — | — | — | — | 11.4K | 478.0K | 0.00% | ↗ |
| 26 | 2019 | Bruce Horowitz, Chief Operating Officer | 277.2K | — | — | — | — | 75.0K | 352.2K | 0.00% | ↗ |
| 27 | 2019 | Timothy C. Scott, Ph.D., Former President | 131.0K | — | — | — | — | 29.0K | 160.0K | 0.00% | ↗ |
| 28 | 2019 | Heather Raines, CPA, Chief Financial Officer | 128.5K | — | 2.3K | — | — | — | 130.8K | 1.76% | ↗ |
| 29 | 2018 | Timothy C. Scott, Ph.D., Former President | 300.0K | — | — | — | — | 28.5K | 328.5K | 0.00% | ↗ |
| 30 | 2018 | Eric Wachter, Ph.D., Chief Technology Officer | 300.0K | — | — | — | — | 28.4K | 328.4K | 0.00% | ↗ |
| 31 | 2018 | Bruce Horowitz, Chief Operating Officer | 190.0K | — | — | — | — | 75.0K | 265.0K | 0.00% | ↗ |
| 32 | 2018 | John Glass, CPA, Former Interim Chief Financial Officer | 234.2K | — | — | — | — | — | 234.2K | 0.00% | ↗ |
| 33 | 2018 | Heather Raines, CPA, Chief Financial Officer | 101.3K | — | — | — | — | — | 101.3K | 0.00% | ↗ |
| 34 | 2017 | John Glass, CPA, Interim Chief Financial Officer | 276.5K | 60.0K | — | — | — | — | 336.5K | 0.00% | ↗ |
| 35 | 2017 | John Glass, CPA, Former Interim Chief Financial Officer | 276.5K | 60.0K | — | — | — | — | 336.5K | 0.00% | ↗ |
| 36 | 2017 | Timothy Scott, Ph.D., President | 300.0K | — | — | — | — | 29.5K | 329.5K | 0.00% | ↗ |
| 37 | 2017 | Timothy C. Scott, Ph.D., Former President | 300.0K | — | — | — | — | 29.5K | 329.5K | 0.00% | ↗ |
| 38 | 2017 | Eric Wachter, Ph.D., Chief Technology Officer | 300.0K | — | — | — | — | 29.5K | 329.5K | 0.00% | ↗ |
| 39 | 2016 | Peter R. Culpepper Former Interim CFO, CAO and COO | 500.0K | — | — | — | — | 123.9K | 623.9K | 0.00% | ↗ |
| 40 | 2016 | Timothy C. Scott President | 500.0K | — | — | — | — | 110.2K | 610.2K | 0.00% | ↗ |
| 41 | 2016 | Eric A. Wachter Chief Technology Officer | 500.0K | — | — | — | — | 101.2K | 601.2K | 0.00% | ↗ |
| 42 | 2016 | Eric Wachter, Ph.D., Chief Technology Officer | 300.0K | — | — | — | — | 110.7K | 410.7K | 0.00% | ↗ |
| 43 | 2016 | Timothy Scott, Ph.D., President | 300.0K | — | — | — | — | 110.2K | 410.2K | 0.00% | ↗ |
| 44 | 2016 | John R. Glass Interim Chief Financial Officer | 138.5K | 20.0K | — | — | — | — | 158.5K | 0.00% | ↗ |
| 45 | 2016 | John Glass, CPA, Interim Chief Financial Officer | 138.5K | 20.0K | — | — | — | — | 158.5K | 0.00% | ↗ |
| 46 | 2016 | H. Craig Dees Former CEO | 83.3K | — | — | — | — | 7.2K | 90.5K | 0.00% | ↗ |
| 47 | 2015 | Peter R. Culpepper Former Interim CFO, CAO and COO | 500.0K | 200.0K | — | 153.3K | — | 110.7K | 964.0K | 15.90% | ↗ |
| 48 | 2015 | Peter R. Culpepper CFO, CAO and COO | 500.0K | 200.0K | — | 153.3K | — | 110.7K | 964.0K | 15.90% | ↗ |
| 49 | 2015 | H. Craig Dees CEO | 500.0K | 200.0K | — | 153.3K | — | 110.7K | 964.0K | 15.90% | ↗ |
| 50 | 2015 | H. Craig Dees Former CEO | 500.0K | 200.0K | — | 153.3K | — | 110.7K | 964.0K | 15.90% | ↗ |
| 51 | 2015 | Timothy C. Scott President | 500.0K | 200.0K | — | 153.3K | — | 110.7K | 964.0K | 15.90% | ↗ |
| 52 | 2015 | Eric A. Wachter Chief Technology Officer | 500.0K | 200.0K | — | 153.3K | — | 110.7K | 964.0K | 15.90% | ↗ |
| 53 | 2014 | Eric A. Wachter Chief Technology Officer | 500.0K | — | — | — | — | 137.7K | 637.7K | 0.00% | ↗ |
| 54 | 2014 | Timothy C. Scott President | 500.0K | — | — | — | — | 137.7K | 637.7K | 0.00% | ↗ |
| 55 | 2014 | Peter R. Culpepper CFO, CAO and COO | 500.0K | — | — | — | — | 137.7K | 637.7K | 0.00% | ↗ |
| 56 | 2014 | H. Craig Dees CEO | 500.0K | — | — | — | — | 137.7K | 637.7K | 0.00% | ↗ |
| 57 | 2014 | H. Craig Dees Former CEO | 500.0K | — | — | — | — | 137.7K | 637.7K | 0.00% | ↗ |
| 58 | 2014 | Peter R. Culpepper Former Interim CFO, CAO and COO | 500.0K | — | — | — | — | 137.7K | 637.7K | 0.00% | ↗ |
| 59 | 2013 | H. Craig Dees CEO | 500.0K | — | — | 28.5K | — | 114.2K | 642.7K | 4.43% | ↗ |
| 60 | 2013 | Timothy C. Scott President | 500.0K | — | — | 28.5K | — | 114.2K | 642.7K | 4.43% | ↗ |
| 61 | 2013 | Eric A. Wachter Chief Technology Officer | 500.0K | — | — | — | — | 114.2K | 614.2K | 0.00% | ↗ |
| 62 | 2013 | Peter R. Culpepper CFO, CAO and COO | 500.0K | — | — | — | — | 114.2K | 614.2K | 0.00% | ↗ |
| 63 | 2012 | H. Craig Dees CEO | 500.0K | 600.0K | — | 36.2K | — | 90.7K | 1.23M | 2.95% | ↗ |
| 64 | 2012 | Timothy C. Scott President | 500.0K | 600.0K | — | 36.2K | — | 90.7K | 1.23M | 2.95% | ↗ |
| 65 | 2012 | Eric A. Wachter Chief Technology Officer | 500.0K | 600.0K | — | — | — | 90.7K | 1.19M | 0.00% | ↗ |
| 66 | 2012 | Peter R. Culpepper CFO, CAO and COO | 500.0K | 600.0K | — | — | — | 90.7K | 1.19M | 0.00% | ↗ |
| 67 | 2011 | H. Craig Dees CEO | 500.0K | 1.60M | — | 821.0K | — | 90.2K | 3.01M | 27.27% | ↗ |
| 68 | 2011 | Eric A. Wachter Chief Technology Officer | 500.0K | 1.60M | — | 821.0K | — | 90.2K | 3.01M | 27.27% | ↗ |
| 69 | 2011 | Timothy C. Scott President | 500.0K | 1.60M | — | 821.0K | — | 90.2K | 3.01M | 27.27% | ↗ |
| 70 | 2011 | Peter R. Culpepper CFO and COO Timothy C. Scott President | 500.0K | 1.60M | — | 821.0K | — | 57.7K | 2.98M | 27.56% | ↗ |
| 71 | 2011 | Timothy C. Scott President Eric A. Wachter EVP - Pharmaceuticals | 500.0K | 1.60M | — | 821.0K | — | 57.7K | 2.98M | 27.56% | ↗ |
| 72 | 2011 | Peter R. Culpepper CFO, CAO and COO | 500.0K | 1.60M | — | 777.5K | — | 90.2K | 2.97M | 26.20% | ↗ |
| 73 | 2011 | Peter R. Culpepper CFO and COO | 500.0K | 1.60M | — | 777.5K | — | 57.7K | 2.94M | 26.49% | ↗ |
| 74 | 2010 | H. Craig Dees CEO | 500.0K | 1.60M | — | 927.2K | — | 181.9K | 3.21M | 28.89% | ↗ |
| 75 | 2010 | Timothy C. Scott President | 500.0K | 1.60M | — | 927.2K | — | 181.9K | 3.21M | 28.89% | ↗ |
| 76 | 2010 | Eric A. Wachter Chief Technology Officer | 500.0K | 1.60M | — | 927.2K | — | 181.9K | 3.21M | 28.89% | ↗ |
| 77 | 2010 | Timothy C. Scott President | 500.0K | 1.60M | — | 927.2K | — | 57.7K | 3.08M | 30.06% | ↗ |
| 78 | 2010 | Peter R. Culpepper CFO and COO Timothy C. Scott President | 500.0K | 1.60M | — | 927.2K | — | 57.7K | 3.08M | 30.06% | ↗ |
| 79 | 2010 | Timothy C. Scott President Eric A. Wachter EVP - Pharmaceuticals | 500.0K | 1.60M | — | 927.2K | — | 57.7K | 3.08M | 30.06% | ↗ |
| 80 | 2010 | Eric A. Wachter EVP - Pharmaceuticals | 500.0K | 1.60M | — | 927.2K | — | 57.7K | 3.08M | 30.06% | ↗ |
| 81 | 2010 | H. Craig Dees CEO | 500.0K | 1.60M | — | 927.2K | — | 57.7K | 3.08M | 30.06% | ↗ |
| 82 | 2009 | Timothy C. Scott President | 500.0K | 518.5K | — | 46.2K | — | 43.3K | 1.11M | 4.17% | ↗ |
| 83 | 2009 | Peter R. Culpepper CFO and COO Timothy C. Scott President | 500.0K | 518.5K | — | 46.2K | — | 43.3K | 1.11M | 4.17% | ↗ |
| 84 | 2009 | Timothy C. Scott President Eric A. Wachter EVP - Pharmaceuticals | 500.0K | 518.5K | — | 46.2K | — | 43.3K | 1.11M | 4.17% | ↗ |
| 85 | 2009 | Eric A. Wachter EVP - Pharmaceuticals | 500.0K | 518.5K | — | 46.2K | — | 43.3K | 1.11M | 4.17% | ↗ |
| 86 | 2009 | H. Craig Dees CEO | 500.0K | 518.5K | — | 46.2K | — | 43.3K | 1.11M | 4.17% | ↗ |
| 87 | 2009 | H. Craig Dees CEO | 500.0K | 518.5K | — | 46.2K | — | 43.3K | 1.11M | 4.17% | ↗ |
| 88 | 2008 | H. Craig Dees, CEO | 450.0K | 146.1K | — | 470.5K | — | 37.5K | 1.10M | 42.61% | ↗ |
| 89 | 2008 | Eric A. Wachter, EVP - Pharmaceuticals | 450.0K | 146.1K | — | 470.5K | — | 37.5K | 1.10M | 42.61% | ↗ |
| 90 | 2008 | Timothy C. Scott, President | 450.0K | 146.1K | — | 470.5K | — | 37.5K | 1.10M | 42.61% | ↗ |
| 91 | 2008 | Peter R. Culpepper, Chief Financial Officer, Chief Operating Officer | 450.0K | 146.1K | — | 435.9K | — | 37.5K | 1.07M | 40.76% | ↗ |
| 92 | 2007 | Peter R. Culpepper, Chief Financial Officer, Chief Operating Officer | 375.0K | 345.0K | — | 578.5K | — | 31.7K | 1.33M | 43.49% | ↗ |
| 93 | 2007 | Timothy C. Scott, President | 375.0K | 345.0K | — | 564.1K | — | 31.7K | 1.32M | 42.87% | ↗ |
| 94 | 2007 | H. Craig Dees, CEO | 375.0K | 345.0K | — | 564.1K | — | 31.7K | 1.32M | 42.87% | ↗ |
| 95 | 2007 | Eric A. Wachter, EVP - Pharmaceuticals | 375.0K | 345.0K | — | 564.1K | — | 31.7K | 1.32M | 42.87% | ↗ |
| 96 | 2006 | Timothy C. Scott, President | 333.3K | 127.3K | — | 459.2K | — | 30.3K | 950.1K | 48.33% | ↗ |
| 97 | 2006 | H. Craig Dees, CEO | 333.3K | 127.3K | — | 459.2K | — | 30.3K | 950.1K | 48.33% | ↗ |
| 98 | 2006 | Eric A. Wachter, EVP - Pharmaceuticals | 333.3K | 127.3K | — | 459.2K | — | 30.3K | 950.1K | 48.33% | ↗ |
| 99 | 2006 | Eric A. Wachter, VP - Pharmaceuticals | 333.3K | 127.3K | — | 459.2K | — | 30.3K | 950.1K | 48.33% | ↗ |
| 100 | 2006 | Peter R. Culpepper, Chief Financial Officer, Chief Operating Officer | 333.3K | 127.3K | — | 436.8K | — | 30.3K | 927.8K | 47.08% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dominic Rodrigues | President & Executive Vice Chairman of the Board | 315.0K | male |
| Edward V. Pershing | Chief Executive Officer & Executive Chairman of Board | 245.0K | male |
| Eric A. Wachter | Co-Founder & Chief Technology Officer | 240.0K | — |
| Heather Raines | Chief Financial Officer | 125.0K | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PVCT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
